Alewife Park | 36-64 Whittemore Ave. | Cambridge

IMG_6487.jpeg

The fences are down around part of the parking area, so you can get pretty close to the building.

IMG_6486.jpeg

Pilings have been installed for one structure in the foreground, and a foundation is installed in the background. I doubt there will be much further work until the market loosens up.
 

IQHQ Partners with Lila Sciences for 244,000 SF Lease at Alewife Park​

“IQHQ, Inc., a premier owner and developer of world-class life science districts, has announced that Lila Sciences, Inc. (Lila), an “AI for Science” company developing the world’s first scientific superintelligence platform and fully autonomous laboratories for life and materials sciences, has signed a 244,000 square foot lease at IQHQ’s Alewife Park district. The Lila lease and IQHQ’s accelerating leasing momentum across its premium quality portfolio fueled IQHQ’s recently closed $310 million capital raise….”

1760693060700.jpeg

IQHQ Partners with Lila Sciences for 244,000 SF Lease at Alewife Park

IQHQ Partners with Lila Sciences for 244,000 SF Lease at Alewife Park
www.bldup.com www.bldup.com
 
Last edited:
244k is basically the square footage that has been completed. This article doesn’t seem to indicate that IQHQ will be building out the remaining sites yet.
 
Well, at least they're doing it here lol.

I was at a talk recently given by scientists from another pharma AI startup in Cambridge that's raised hundreds of millions and is now trying to IPO in China. They already do contract wetlab work over there for reasons of speed/cost and my impression was that they're interested in moving everything over there. Low key I think we will need significant automation if we are going to prevent offshoring of high end pharma R&D.
 
sean99090900 said:
Well, at least they're doing it here lol.

I was at a talk recently given by scientists from another pharma AI startup in Cambridge that's raised hundreds of millions and is now trying to IPO in China. They already do contract wetlab work over there for reasons of speed/cost and my impression was that they're interested in moving everything over there. Low key I think we will need significant automation if we are going to prevent offshoring of high end pharma R&D.
Click to expand...
Well what can go wrong in off-shoring biotech research to China...
 
Offshoring pharma has been a buzzword for decades. First is was India, then China, then all back to the US and now I'm hearing India again for higher level research and now China again.

China is rapidly catching up on biotech innovation, but as long as we keep our foot on the gas pedal, we will stay out front. Why? The cost savings you get in other global markets is shrinking and the ROI never seems to pan out. Even here in the US, many LCOL metros can barely get tenants for their tiny biotech innovation parks even with loads of tenant improvement and tax incentive dollars.

I have been through this over and over again. Our company tried and tried to get people to move to our Midwest lab locations and it was impossible. No luck with local talent either. So, in the end, we always ended up paying up for space in Boston and hiring people and we get a ton of qualified candidates, plus landlords, HVAC and electrical contractors that know the biotech world.
 
Czervik.Construction said:
Offshoring pharma has been a buzzword for decades. First is was India, then China, then all back to the US and now I'm hearing India again for higher level research and now China again.

China is rapidly catching up on biotech innovation, but as long as we keep our foot on the gas pedal, we will stay out front. Why? The cost savings you get in other global markets is shrinking and the ROI never seems to pan out. Even here in the US, many LCOL metros can barely get tenants for their tiny biotech innovation parks even with loads of tenant improvement and tax incentive dollars.

I have been through this over and over again. Our company tried and tried to get people to move to our Midwest lab locations and it was impossible. No luck with local talent either. So, in the end, we always ended up paying up for space in Boston and hiring people and we get a ton of qualified candidates, plus landlords, HVAC and electrical contractors that know the biotech world.
Click to expand...
The basic science looks like it's increasingly there, the number of chinese papers I'm reading seems to be increasing every year. A chinese post doc was also telling me that a biotech over there was doing research on 3 shifts, 24 hours per day. I don't know if that particular anecdote is true, but the desperation to find white collar work for many over there does seem to be unbelievably intense.

I hope you're right about the persistence of US biotech though, particularly Boston since I wanna stay 😭. What I do worry about more than cost of labor though is that chinese industry in general is increasingly more capital intense than ours is, (more industrial robotics, etc.). Hopefully Lila or someone like them can figure out how to make tools so good none of this is relevant. That and I'm worried policy makers won't realize that we need to create a better academic/investment/business environment and instead continue to see the industry as some kind of golden goose to shake down.
 
You must log in or register to reply here.

Back
Top